210 related articles for article (PubMed ID: 36298703)
21. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
[TBL] [Abstract][Full Text] [Related]
22. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological and Genomic Analysis of Asymptomatic SARS-CoV-2 Infections during the Delta and Omicron Epidemic Waves in São Paulo City, Brazil.
Slavov SN; Lima ARJ; Ribeiro G; de Lima LPO; Barros CRDS; Marqueze EC; Martins AJ; Martininghi M; Palmieri M; Caldeira LAV; Silva FEVD; Cacherik G; Nicolodelli AL; Kashima S; Giovanetti M; Alcantara LCJ; Sampaio SC; Elias MC
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005887
[TBL] [Abstract][Full Text] [Related]
24. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
[TBL] [Abstract][Full Text] [Related]
25. A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.
Schultz BM; Melo-González F; Duarte LF; Gálvez NMS; Pacheco GA; Soto JA; Berríos-Rojas RV; González LA; Moreno-Tapia D; Rivera-Pérez D; Ríos M; Vázquez Y; Hoppe-Elsholz G; Andrade-Parra CA; Vallejos OP; Piña-Iturbe A; Iturriaga C; Urzua M; Navarrete MS; Rojas Á; Fasce R; Fernández J; Mora J; Ramírez E; Gaete-Argel A; Acevedo ML; Valiente-Echeverría F; Soto-Rifo R; Weiskopf D; Grifoni A; Sette A; Zeng G; Meng W; ; González-Aramundiz JV; González PA; Abarca K; Kalergis AM; Bueno SM
mBio; 2022 Aug; 13(4):e0142322. PubMed ID: 35946814
[TBL] [Abstract][Full Text] [Related]
26. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
27. Wastewater surveillance monitoring of SARS-CoV-2 variants of concern and dynamics of transmission and community burden of COVID-19.
Hasing ME; Lee BE; Gao T; Li Q; Qiu Y; Ellehoj E; Graber TE; Fuzzen M; Servos M; Landgraff C; Delatolla R; Tipples G; Zelyas N; Hinshaw D; Maal-Bared R; Sikora C; Parkins M; Hubert CRJ; Frankowski K; Hrudey SE; Pang XL
Emerg Microbes Infect; 2023 Dec; 12(2):2233638. PubMed ID: 37409382
[TBL] [Abstract][Full Text] [Related]
28. Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.
Gularte JS; da Silva MS; Mosena ACS; Demoliner M; Hansen AW; Filippi M; Pereira VMAG; Heldt FH; Weber MN; de Almeida PR; Hoffmann AT; Valim ARM; Possuelo LG; Fleck JD; Spilki FR
Virus Res; 2022 Apr; 311():198702. PubMed ID: 35104582
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil.
Naveca FG; Nascimento VA; Nascimento F; Ogrzewalska M; Pauvolid-Corrêa A; Araújo MF; Arantes I; Batista ÉR; Magalhães AÁ; Vinhal F; Mattos TP; Riediger I; Debur MDC; Grinsztejn B; Veloso VG; Brasil P; Rodrigues RR; Rovaris DB; Fernandes SB; Fernandes C; Santos JHA; Abdalla LF; Costa-Filho R; Silva M; Souza V; Costa ÁA; Mejía M; Brandão MJ; Gonçalves LF; Silva GA; de Jesus MS; Pessoa K; Corado ALG; Duarte DCG; Machado AB; Zukeram KA; Valente N; Lopes RS; Pereira EC; Appolinario LR; Rocha AS; Tort LFL; Sekizuka T; Itokawa K; Hashino M; Kuroda M; Dezordi FZ; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Bello G; Resende PC
Sci Rep; 2023 May; 13(1):7306. PubMed ID: 37147348
[TBL] [Abstract][Full Text] [Related]
30. New infections by SARS-CoV-2 variants of concern after natural infections and post-vaccination in Rio de Janeiro, Brazil.
Goes LR; Siqueira JD; Garrido MM; Alves BM; Pereira ACPM; Cicala C; Arthos J; Viola JPB; Soares MA;
Infect Genet Evol; 2021 Oct; 94():104998. PubMed ID: 34252616
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
Banerjee A; Lew J; Kroeker A; Baid K; Aftanas P; Nirmalarajah K; Maguire F; Kozak R; McDonald R; Lang A; Gerdts V; Straus SE; Gilbert L; Li AX; Mozafarihashjin M; Walmsley S; Gingras AC; Wrana JL; Mazzulli T; Colwill K; McGeer AJ; Mubareka S; Falzarano D
Med; 2022 Jun; 3(6):422-432.e3. PubMed ID: 35437520
[TBL] [Abstract][Full Text] [Related]
32. Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021-January 2022.
Gerashchenko GV; Hryshchenko NV; Melnichuk NS; Marchyshak TV; Chernushyn SY; Demchyshina IV; Chernenko LM; Kuzin IV; Tkachuk ZY; Kashuba VI; Tukalo MA
Heliyon; 2024 Feb; 10(4):e25618. PubMed ID: 38380034
[TBL] [Abstract][Full Text] [Related]
33. Dynamic clade transitions and the influence of vaccine rollout on the spatiotemporal circulation of SARS-CoV-2 variants in São Paulo, Brazil.
Banho CA; de Carvalho Marques B; Sacchetto L; Sepedro Lima AK; Pereira Parra MC; Jeronimo Lima AR; Ribeiro G; Jorge Martins A; Dos Santos Barros CR; Carolina Elias M; Coccuzzo Sampaio S; Nanev Slavov S; Strazza Rodrigues E; Vieira Santos E; Tadeu Covas D; Kashima S; Augusto Brassaloti R; Petry B; Gaspar Clemente L; Lehmann Coutinho L; Akemi Assato P; da Silva da Costa FA; Souza-Neto JA; Maria Tommasini Grotto R; Daiana Poleti M; Cristina Chagas Lesbon J; Chicaroni Mattos E; Fukumasu H; Giovanetti M; Carlos Junior Alcantara L; Rahal P; Pessoa Araújo JF; Althouse BM; Vasilakis N; Lacerda Nogueira M
Res Sq; 2024 Jan; ():. PubMed ID: 38343798
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled, phase 2 trial.
Zhang Y; Ma X; Yan G; Wu Y; Chen Y; Zhou Z; Wan N; Su W; Liu FW; Dai MX; Yang M; Li C; Yu X; Zhang L; Wang Z; Zhou TC; You D; Wei J; Zhang Z;
EClinicalMedicine; 2022 Dec; 54():101680. PubMed ID: 36188435
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
36. Transmission dynamics of
Pinho CT; Vidal AF; Negri Rocha TC; Oliveira RRM; da Costa Barros MC; Closset L; Azevedo-Pinheiro J; Braga-da-Silva C; Silva CS; Magalhães LL; do Carmo Pinto PD; Souza GBS; Dos Santos Vieira JR; Burbano RMR; de Sousa MS; de Souza JES; Nunes G; da Silva MB; da Costa PF; Salgado CG; Sousa RCM; Degrave WMS; Ribeiro-Dos-Santos Â; Oliveira G
Front Public Health; 2023; 11():1186463. PubMed ID: 37790714
[TBL] [Abstract][Full Text] [Related]
37. Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil.
de Oliveira LA; de Rezende IM; Navarini VJ; Marchioro SB; Torres AJL; Croda J; Croda MG; Gonçalves CCM; Xavier J; de Castro E; Lima M; Iani F; Adelino T; Aburjaile F; Ferraz Demarchi LH; Taira DL; Zardin MCSU; Fonseca V; Giovanetti M; Andrews J; Alcantara LCJ; Simionatto S
Front Public Health; 2023; 11():1195779. PubMed ID: 37965526
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil.
Campos KR; Sacchi CT; Abbud A; Caterino-de-Araujo A
Rev Panam Salud Publica; 2021; 45():e126. PubMed ID: 34707647
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.
Freire-Neto FP; Teixeira DG; da Cunha DCS; Morais IC; Tavares CPM; Gurgel GP; Medeiros SDN; Santos DCD; Sales AO; Jeronimo SMB
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010337. PubMed ID: 36191040
[TBL] [Abstract][Full Text] [Related]
40. Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas.
Arantes I; Bello G; Nascimento V; Souza V; da Silva A; Silva D; Nascimento F; Mejía M; Brandão MJ; Gonçalves L; Silva G; da Costa CF; Abdalla L; Santos JH; Ramos TCA; Piantham C; Ito K; Siqueira MM; Resende PC; Wallau GL; Delatorre E; Gräf T; Naveca FG
Nat Commun; 2023 Apr; 14(1):2048. PubMed ID: 37041143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
